Novo Nordisk looks to shore up European market share

COPENHAGEN, June 2 (Reuters) - Novo Nordisk, the world's biggest maker of diabetes drugs, will focus on growing volumes rather than price in its key European market where it has lost ground to competitors in recent years, a senior executive said on Friday.

by reutersCOMPANYNEWS via Endless Supplies .Biz - News